Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Luminex Corp (LMNX)

Luminex Corp (LMNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,486,398
  • Shares Outstanding, K 46,363
  • Annual Sales, $ 334,640 K
  • Annual Income, $ -3,840 K
  • 60-Month Beta 0.71
  • Price/Sales 4.59
  • Price/Cash Flow 77.50
  • Price/Book 3.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.21
  • Number of Estimates 3
  • High Estimate 0.24
  • Low Estimate 0.19
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +275.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.36 +2.23%
on 07/08/20
41.69 -23.10%
on 08/05/20
-0.31 (-0.96%)
since 07/07/20
3-Month
27.59 +16.20%
on 06/22/20
41.69 -23.10%
on 08/05/20
-6.77 (-17.43%)
since 05/07/20
52-Week
17.34 +84.84%
on 11/05/19
41.69 -23.10%
on 08/05/20
+10.82 (+50.94%)
since 08/07/19

Most Recent Stories

More News
SmarTrend Watching for Potential Rebound in Shares of Luminex Corp After 14.86% Loss

Luminex Corp (NASDAQ:LMNX) traded in a range yesterday that spanned from a low of $34.35 to a high of $40.65. Yesterday, the shares fell 14.9%, which took the trading range below the 3-day low of $36.91...

LMNX : 32.06 (-3.20%)
Luminex (LMNX) Q2 Earnings Beat Estimates, Revenues Miss

Luminex (LMNX) witnessed total sample-to-answer molecular diagnostics revenue growth in Q2

LMNX : 32.06 (-3.20%)
PKI : 119.33 (+0.24%)
TMO : 414.33 (-0.34%)
OPK : 5.63 (-0.44%)
Luminex (LMNX) Q2 Earnings Surpass Estimates

Luminex (LMNX) delivered earnings and revenue surprises of 237.50% and -0.07%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

LMNX : 32.06 (-3.20%)
Luminex: 2Q Earnings Snapshot

AUSTIN, Texas (AP) _ Luminex Corp. (LMNX) on Tuesday reported second-quarter net income of $12.5 million, after reporting a loss in the same period a year earlier.

LMNX : 32.06 (-3.20%)
Luminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of Directors

, /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, , from its Board of Directors ("Board") effective , 2020. 

LMNX : 32.06 (-3.20%)
Luminex Corporation Reports Second Quarter 2020 Results

, /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its second quarter ended .

LMNX : 32.06 (-3.20%)
Bordetella Pertussis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)

, /PRNewswire/ -- Read the full report: Bordetella Pertussis Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market...

HOLX : 68.55 (-2.42%)
LMNX : 32.06 (-3.20%)
Canopy Growth (CGC) to Report Q1 Earnings: What's in Store?

Continued momentum from robust product demand is expected to have significantly contributed to Canopy Growth's (CGC) top line in the fiscal first quarter.

LMNX : 32.06 (-3.20%)
RMD : 173.24 (-1.30%)
QGEN : 47.31 (+0.94%)
CGC : 16.63 (-5.08%)
Illumina (ILMN) to Report Q2 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its second-quarter sequencing consumable revenue growth.

ILMN : 355.66 (-10.94%)
LMNX : 32.06 (-3.20%)
IART : 48.09 (+0.59%)
IDXX : 381.76 (-2.06%)
Cell and Gene Therapy Tools, and Reagents: Global Markets

, /PRNewswire/ --  The scope of this study encompasses an investigation of the markets cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral,...

LMNX : 32.06 (-3.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade LMNX with:

Business Summary

Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP...

See More

Key Turning Points

2nd Resistance Point 34.44
1st Resistance Point 33.25
Last Price 32.06
1st Support Level 31.39
2nd Support Level 30.72

See More

52-Week High 41.69
Fibonacci 61.8% 32.39
Last Price 32.06
Fibonacci 50% 29.52
Fibonacci 38.2% 26.64
52-Week Low 17.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar